RT Journal Article
SR Electronic
T1 Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005136
DO 10.1136/jitc-2022-005136
VO 10
IS 9
A1 Simonetti, Sonia
A1 Iuliani, Michele
A1 Stellato, Marco
A1 Cavaliere, Silvia
A1 Vincenzi, Bruno
A1 Tonini, Giuseppe
A1 Santini, Daniele
A1 Pantano, Francesco
YR 2022
UL http://jitc.bmj.com/content/10/9/e005136.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.